Shire Shares Rise on Product Outlook

Shire Shares Rise on Product Outlook - Houston Chronicle

Shire Shares Rise on Product Outlook
Houston Chronicle, United States - Apr 2, 2008
Shire will lose patent protection on its ADHD drug Adderall XR next year, but increasing sales of Vyvanse, the bowel disorder drug Lialda and the Hunter …

Find Out More:

Books:

April 4th, 2008
Adderall

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Natural ADHD Treatments

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism